Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegilidine vs fentanyl analgesia after cardiac and great vessel surgery
ChiCTR2600130976Phase 4Not yet recruiting
- Sponsor
- Zhongshan People's Hospital
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tegileridine in postoperative pain (2 arms), sponsored by Zhongshan People's Hospital. Primary endpoints: Mean NRS pain score within 72 hours after surgery, Pain relief target rate and 2 more. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
tegileridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600130976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600130976.